Inozyme is a startup based in the United States, 2 tracked investors.
Inozyme is a startup based in the United States. Brouky records 2 investors associated with the company.
Inozyme Therapeutics develops treatments for rare genetic disorders affecting mineral metabolism, focusing on precision therapeutics to address underlying disease causes.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.